Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2013

Total Assets: $19.6M

Liabilities Breakdown FY2013

Total Liabilities: $6.9M